SYMPTOM-LIMITED, SELF-PACED WALKING IN THE ASSESSMENT OF CARDIOVASCULAR-DISEASE IN PATIENTS WITH AND WITHOUT HEART-FAILURE - THE PREDICTIVE VALUE OF CLINICAL, ANTHROPOMETRIC, ECHOCARDIOGRAPHIC AND ERGONOMETRIC PARAMETERS

被引:7
作者
AJAYI, AA [1 ]
BALOGUN, JA [1 ]
机构
[1] OBAFEMI AWOLOWO UNIV,FAC HLTH SCI,DEPT MED REHABIL,IFE,NIGERIA
关键词
SELF-PACED WALKING; DETERMINANT; HEART DISEASE; HEART FAILURE; LEFT VENTRICULAR SIZE; ENERGY EXPENDITURE;
D O I
10.1016/0167-5273(91)90352-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The assessment of functional capacity in heart disease remains problematic, and it is unclear whether maximal exercise testing is physiologically reflective of the activities of daily living or the quality of life. We therefore employed a symptom-limited, self-paced walking protocol to assess the physical conditions of 41 Nigerian cardiac patients, with and without heart failure. The walking time, walking speed and distance as well as the energy expenditure (Kcal . min-1) were markedly reduced (P < 0.001) in patients with heart failure (n = 26) compared to the cardiac patients not in failure (n = 15). The double product corrected for exercise time (an index of myocardial oxygen use) was, however, significantly higher (P < 0.001) in the group with heart failure. Using multiple regression analysis, the parameters of self-paced walking capacity (distance, walking time, and speed) could reliably be predicted (r2 > 0.9) from age, body surface area, energy expenditure, and echocardiographic left ventricular dimension in the patients without heart failure. The presence of heart failure appeared to weaken the predictability of the regressions. A significant correlation was obtained between the self paced exercise time and the Bruce protocol treadmill time (r2 = 0.91, P = 0.004) in a subgroup of the patients with heart failure. Thus, the self-paced walking test is sensitive to changes in congestive heart failure and the exercise capacity can be predicted from age and biophysical parameters. The wider clinical usage of this modality, especially in frail patients, is hereby recommended.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 18 条
[1]   CORRELATION AMONG RADIOLOGIC, ECHOCARDIOGRAPHIC INDEXES AND SELF PACED-EXERCISE CAPACITY IN HEART-FAILURE [J].
AJAYI, AA ;
BALOGUN, MO ;
AJAYI, AT .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1990, 27 (01) :135-137
[2]   SUSTAINED BENEFICIAL-EFFECTS OF ENALAPRIL IN AFRICANS WITH CONGESTIVE-HEART-FAILURE [J].
AJAYI, AA ;
BALOGUN, MO .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1990, 29 (01) :55-61
[3]   ENERGY-COST DETERMINATION USING A PORTABLE ACCELEROMETER [J].
BALOGUN, JA ;
FARINA, NT ;
FAY, E ;
ROSSMANN, K ;
POZYC, L .
PHYSICAL THERAPY, 1986, 66 (07) :1102-1107
[4]   CALORIMETRIC VALIDATION OF THE CALTRAC ACCELEROMETER DURING LEVEL WALKING [J].
BALOGUN, JA ;
MARTIN, DA ;
CLENDENIN, MA .
PHYSICAL THERAPY, 1989, 69 (06) :501-509
[5]   FACTORS AFFECTING THE HEART-RATE DURING SELF-PACED WALKING [J].
BASSEY, EJ ;
MACDONALD, IA ;
PATRICK, JM .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 1982, 48 (01) :105-115
[6]  
BASSEY EJ, 1975, CLIN SCI MOL MED, V51, P609
[7]   A SELF PACED TREADMILL WALKING TEST FOR BREATHLESS PATIENTS [J].
BEAUMONT, A ;
COCKCROFT, A ;
GUZ, A .
THORAX, 1985, 40 (06) :459-464
[8]   EXERCISE CAPACITY AND QUALITY OF LIFE IN THE TREATMENT OF HEART-FAILURE [J].
BLACKWOOD, R ;
MAYOU, RA ;
GARNHAM, JC ;
ARMSTRONG, C ;
BRYANT, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :325-332
[9]   MAXIMAL OXYGEN INTAKE AND NOMOGRAPHIC ASSESSMENT OF FUNCTIONAL AEROBIC IMPAIRMENT IN CARDIOVASCULAR DISEASE [J].
BRUCE, RA ;
KUSUMI, F ;
HOSMER, D .
AMERICAN HEART JOURNAL, 1973, 85 (04) :546-562
[10]   MEASUREMENT OF THE QUALITY OF LIFE IN CONGESTIVE HEART-FAILURE - INFLUENCE OF DRUG-THERAPY [J].
BULPITT, CJ ;
FLETCHER, AE .
CARDIOVASCULAR DRUGS AND THERAPY, 1988, 2 :419-424